Pharmacokinetic considerations for treatment of bacterial peritonitis during continuous ambulatory peritoneal dialysis

Contrib Nephrol. 1991:89:96-107. doi: 10.1159/000419756.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Bacterial Infections / drug therapy*
  • Cefotaxime / pharmacokinetics*
  • Cefotaxime / therapeutic use
  • Female
  • Fosfomycin / pharmacokinetics*
  • Fosfomycin / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Moxalactam / pharmacokinetics*
  • Moxalactam / therapeutic use
  • Peritoneal Dialysis, Continuous Ambulatory*
  • Peritonitis / drug therapy*

Substances

  • Fosfomycin
  • Cefotaxime
  • Moxalactam